Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis

5Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chondrocyte and its anti-inflammatory effect, we conducted a prospective interventional cohort study where we evaluate the efficacy and safety of oral low-dose GC in one hundred women with EDPOA. The pain intensity, number of tender joints as well as impact in co-morbidities were analyzed. We conclude that the use of low-dose GC in patients with EDPOA can be an effective and a safe therapeutic option. © 2013 Springer-Verlag.

Cite

CITATION STYLE

APA

Cañas, C. A., Osorio, C. J., Coronel, N., Cepeda, M. C., Izquierdo, J. H., & Bonilla-Abadía, F. (2014). Efficacy and safety of oral low-dose glucocorticoids in patients with estrogen-dependent primary osteoarthritis. Rheumatology International, 34(5), 733–735. https://doi.org/10.1007/s00296-012-2603-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free